Abingdon Health Plc (AIM:ABDX)
London
· Delayed Price · Currency is GBP · Price in GBX 7.00
-0.49 (-7.00%)
Jun 20, 2025, 4:35 PM GMT+1
Abingdon Health Market Cap
Abingdon Health has a market cap or net worth of 26.32 million as of June 20, 2025. Its market cap has decreased by -22.58% in one year.
Market Cap
26.32M
Enterprise Value
23.65M
Revenue
6.82M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.00
Market Cap Chart
Since December 15, 2020, Abingdon Health's market cap has decreased from 100.96M to 26.32M, a decrease of -73.93%. That is a compound annual growth rate of -25.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2025 | 26.32M | -11.84% |
| Dec 31, 2024 | 29.85M | -10.74% |
| Dec 29, 2023 | 33.44M | 69.23% |
| Dec 30, 2022 | 19.76M | -80.30% |
| Dec 31, 2021 | 100.33M | 10.94% |
| Dec 31, 2020 | 90.44M | -10.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 163.63B |
| GSK plc | 58.11B |
| Haleon | 34.38B |
| Smith & Nephew | 9.40B |
| ConvaTec Group | 5.72B |
| Hikma Pharmaceuticals | 4.53B |
| HUTCHMED (China) | 1.88B |
| Indivior | 1.28B |